Reset Map6 Results
22 Station Road Cambridge, Cambridgeshire, CB1 2JD United KingdomHelios Global Group is an independent, full-service healthcare communications network comprising three specialist medical communications agencies—Helios, Selene and Apollo—alongside a dedicated market access and HEOR agency, Cogentia. Founded in 2015, we are a science-first organisation driven by a desire to do medical communications differently. We deliver impactful, scientifically rigorous solutions that educate, influence behaviour and help shape the future of patient care. Our integrated expertise spans strategic consultancy, medical and scientific communications, commercialisation, and evidence, value and market access—supported by in-house studio, digital, innovation and editorial teams. Our therapeutic expertise is both broad and deep, encompassing cardiovascular and metabolic disease, cell and gene therapies, gastrointestinal disorders, haematology, infectious diseases, inflammation and immunology, neurology and pain, oncology and haematological oncology, ophthalmology, and rare diseases. With more than 300 professionals across five offices in the UK and USA, scientific excellence underpins everything we do. Over 70% of our client-facing team hold PhDs or higher degrees, and our industry-leading retention rate—consistently above 90%—reflects our commitment to being a great place to work and a trusted partner to our clients. Independent, agile and collaborative, we tailor our approach to meet each client’s unique challenges. In 2025, 90% of surveyed clients (N=87) rated Helios as better or much better than other agencies they had worked with. We are proud to have been awarded an EcoVadis Silver Medal in 2025 and remain firmly committed to the Science Based Targets initiative (SBTi).
23FC Mereside Alderley Park Alderley Edge, Cheshire, SK10 4TG United KingdomHelios Global Group is an independent, full-service healthcare communications network comprising three specialist medical communications agencies—Helios, Selene and Apollo—alongside a dedicated market access and HEOR agency, Cogentia. Founded in 2015, we are a science-first organisation driven by a desire to do medical communications differently. We deliver impactful, scientifically rigorous solutions that educate, influence behaviour and help shape the future of patient care. Our integrated expertise spans strategic consultancy, medical and scientific communications, commercialisation, and evidence, value and market access—supported by in-house studio, digital, innovation and editorial teams. Our therapeutic expertise is both broad and deep, encompassing cardiovascular and metabolic disease, cell and gene therapies, gastrointestinal disorders, haematology, infectious diseases, inflammation and immunology, neurology and pain, oncology and haematological oncology, ophthalmology, and rare diseases. With more than 300 professionals across five offices in the UK and USA, scientific excellence underpins everything we do. Over 70% of our client-facing team hold PhDs or higher degrees, and our industry-leading retention rate—consistently above 90%—reflects our commitment to being a great place to work and a trusted partner to our clients. Independent, agile and collaborative, we tailor our approach to meet each client’s unique challenges. In 2025, 90% of surveyed clients (N=87) rated Helios as better or much better than other agencies they had worked with. We are proud to have been awarded an EcoVadis Silver Medal in 2025 and remain firmly committed to the Science Based Targets initiative (SBTi).
350 Goose Lane, Building B, Suite 202 Guilford, CT, CT 06437 United KingdomHelios Global Group is an independent, full-service healthcare communications network comprising three specialist medical communications agencies—Helios, Selene and Apollo—alongside a dedicated market access and HEOR agency, Cogentia. Founded in 2015, we are a science-first organisation driven by a desire to do medical communications differently. We deliver impactful, scientifically rigorous solutions that educate, influence behaviour and help shape the future of patient care. Our integrated expertise spans strategic consultancy, medical and scientific communications, commercialisation, and evidence, value and market access—supported by in-house studio, digital, innovation and editorial teams. Our therapeutic expertise is both broad and deep, encompassing cardiovascular and metabolic disease, cell and gene therapies, gastrointestinal disorders, haematology, infectious diseases, inflammation and immunology, neurology and pain, oncology and haematological oncology, ophthalmology, and rare diseases. With more than 300 professionals across five offices in the UK and USA, scientific excellence underpins everything we do. Over 70% of our client-facing team hold PhDs or higher degrees, and our industry-leading retention rate—consistently above 90%—reflects our commitment to being a great place to work and a trusted partner to our clients. Independent, agile and collaborative, we tailor our approach to meet each client’s unique challenges. In 2025, 90% of surveyed clients (N=87) rated Helios as better or much better than other agencies they had worked with. We are proud to have been awarded an EcoVadis Silver Medal in 2025 and remain firmly committed to the Science Based Targets initiative (SBTi).
350 Goose Lane, Building B, Suite 202 Guilford, CT, CT 06437 United StatesHelios Global Group is an independent, full-service healthcare communications network comprising three specialist medical communications agencies—Helios, Selene and Apollo—alongside a dedicated market access and HEOR agency, Cogentia. Founded in 2015, we are a science-first organisation driven by a desire to do medical communications differently. We deliver impactful, scientifically rigorous solutions that educate, influence behaviour and help shape the future of patient care. Our integrated expertise spans strategic consultancy, medical and scientific communications, commercialisation, and evidence, value and market access—supported by in-house studio, digital, innovation and editorial teams. Our therapeutic expertise is both broad and deep, encompassing cardiovascular and metabolic disease, cell and gene therapies, gastrointestinal disorders, haematology, infectious diseases, inflammation and immunology, neurology and pain, oncology and haematological oncology, ophthalmology, and rare diseases. With more than 300 professionals across five offices in the UK and USA, scientific excellence underpins everything we do. Over 70% of our client-facing team hold PhDs or higher degrees, and our industry-leading retention rate—consistently above 90%—reflects our commitment to being a great place to work and a trusted partner to our clients. Independent, agile and collaborative, we tailor our approach to meet each client’s unique challenges. In 2025, 90% of surveyed clients (N=87) rated Helios as better or much better than other agencies they had worked with. We are proud to have been awarded an EcoVadis Silver Medal in 2025 and remain firmly committed to the Science Based Targets initiative (SBTi).
350 Goose Ln Guilford, CT, 06437 2491 United StatesHelios Global Group is an independent, full-service healthcare communications network comprising three specialist medical communications agencies—Helios, Selene and Apollo—alongside a dedicated market access and HEOR agency, Cogentia. Founded in 2015, we are a science-first organisation driven by a desire to do medical communications differently. We deliver impactful, scientifically rigorous solutions that educate, influence behaviour and help shape the future of patient care. Our integrated expertise spans strategic consultancy, medical and scientific communications, commercialisation, and evidence, value and market access—supported by in-house studio, digital, innovation and editorial teams. Our therapeutic expertise is both broad and deep, encompassing cardiovascular and metabolic disease, cell and gene therapies, gastrointestinal disorders, haematology, infectious diseases, inflammation and immunology, neurology and pain, oncology and haematological oncology, ophthalmology, and rare diseases. With more than 300 professionals across five offices in the UK and USA, scientific excellence underpins everything we do. Over 70% of our client-facing team hold PhDs or higher degrees, and our industry-leading retention rate—consistently above 90%—reflects our commitment to being a great place to work and a trusted partner to our clients. Independent, agile and collaborative, we tailor our approach to meet each client’s unique challenges. In 2025, 90% of surveyed clients (N=87) rated Helios as better or much better than other agencies they had worked with. We are proud to have been awarded an EcoVadis Silver Medal in 2025 and remain firmly committed to the Science Based Targets initiative (SBTi).
23FC Mereside, Alderley Park, Alderley Edge Cheshire, SK10 4TG United KingdomHelios Global Group is an independent, full-service healthcare communications network comprising three specialist medical communications agencies—Helios, Selene and Apollo—alongside a dedicated market access and HEOR agency, Cogentia. Founded in 2015, we are a science-first organisation driven by a desire to do medical communications differently. We deliver impactful, scientifically rigorous solutions that educate, influence behaviour and help shape the future of patient care. Our integrated expertise spans strategic consultancy, medical and scientific communications, commercialisation, and evidence, value and market access—supported by in-house studio, digital, innovation and editorial teams. Our therapeutic expertise is both broad and deep, encompassing cardiovascular and metabolic disease, cell and gene therapies, gastrointestinal disorders, haematology, infectious diseases, inflammation and immunology, neurology and pain, oncology and haematological oncology, ophthalmology, and rare diseases. With more than 300 professionals across five offices in the UK and USA, scientific excellence underpins everything we do. Over 70% of our client-facing team hold PhDs or higher degrees, and our industry-leading retention rate—consistently above 90%—reflects our commitment to being a great place to work and a trusted partner to our clients. Independent, agile and collaborative, we tailor our approach to meet each client’s unique challenges. In 2025, 90% of surveyed clients (N=87) rated Helios as better or much better than other agencies they had worked with. We are proud to have been awarded an EcoVadis Silver Medal in 2025 and remain firmly committed to the Science Based Targets initiative (SBTi).
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.